Immune Checkpoint Inhibitors Safe, Effective in Older Cancer Patients

A retrospective study of ICIs by French investigators found manageable toxicity in patients over age 70, and survival outcomes comparable to younger patients.

Source: CancerNetwork - May 4, 2018 Category: Cancer & Oncology Authors: John Schieszer Tags: Immuno Oncology News Older Patients Source Type: news